Back to search
Neovascular Age-related Macular Edema
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neovascular Age-related Macular Edema trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neovascular Age-related Macular Edema trials you may qualify forThe FaReal study aims to evaluate the effectiveness, safety, clinical insights and treatment patterns in patients treated with faricimab, in neovascular age-rel…
The main goal of this study is to find out how common certain eye diseases are in Germany and how they have changed over time. The diseases being studied are:…
The Farseeing Study will explore long-term effectiveness, safety, and treatment patterns among patients being treated with faricimab in real-world, routine clin…
EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema…
This study aims to investigate the impact of intravitreal injection of anti-vascular endothelial growth factor (anti VEGF) Faricimab on renal function of diabet…
Age-related macular degeneration (AMD) and diabetic retinopathy are among the most common disorders causing visual disability in elderly people. AMD leads to dy…
The purpose of this research study is to test whether a personalised care approach improves adherence compared to standard care. Many patients with macular dise…
This is an observational study in which only data are collected from people who have already been prescribed aflibercept 8 mg by their own doctors. In this stu…